TNYA
TNYA
NASDAQ · Biotechnology

Tenaya Therapeutics Inc

$0.67
-0.04 (-5.11%)
As of Mar 29, 10:36 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +5,335.3% upside
Low Target $26.32
Average Target $36.15
High Target $48.95
Current Price $0.67
Current
$0.67
Target
$36.15
$26.32 $36.15 avg $48.95
Scenario Analysis
Bear Case
$26.32
3,857.3%
Low target
Base Case
$36.15
+5,335.3%
Avg target
Bull Case
$48.95
+7,259.8%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.35
-71.7% from high
52-Week Low
$0.36
+84.8% from low
Target vs 52W High
$36.15
+1,438.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%